EP1126013B2 - Cleaning composition for medical devices - Google Patents
Cleaning composition for medical devices Download PDFInfo
- Publication number
- EP1126013B2 EP1126013B2 EP01100242A EP01100242A EP1126013B2 EP 1126013 B2 EP1126013 B2 EP 1126013B2 EP 01100242 A EP01100242 A EP 01100242A EP 01100242 A EP01100242 A EP 01100242A EP 1126013 B2 EP1126013 B2 EP 1126013B2
- Authority
- EP
- European Patent Office
- Prior art keywords
- accordance
- cleaning
- surfactants
- ampho
- alkyl group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/66—Non-ionic compounds
- C11D1/72—Ethers of polyoxyalkylene glycols
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/26—Organic compounds containing nitrogen
- C11D3/33—Amino carboxylic acids
Definitions
- the present invention relates to the use of liquid detergents containing surfactants, corrosion inhibitors and other additives that enhance cleaning for cleaning medical instruments, in particular for cleaning flexible endoscopes by removing X-ray contrast agents.
- Endoscopes are tubular or tubular instruments used to examine body cavities and hollow organs. They are equipped with an optical system consisting of lens and eyepiece, a lighting device and usually rinsing and suction devices and channels for introducing special instruments.
- Flexible endoscopes (which are also referred to as fiber endoscopes) are equipped with a fiber optic light guide, which consists of a tightly packed bundle of hair-thin and therefore highly flexible individual fibers. Due to the flexibility of the glass fibers, light and image can be transmitted via virtually any bend.
- the fiber bundles and the Bowden cables for the movement of the tip channels for flushing and air and a generally larger biopsy and at the same time suction duct are housed.
- the endoscopy alone, for example, for the removal of tissue samples, but also in combination with other methods, such.
- ultrasound endoscopic ultrasonography
- X-ray diagnostics are performed.
- X-ray contrast images of the gallbladder and the bile ducts and of the pancreatic duct system are commonly used. This is -. B. in the context of an endoscopic retrograde cholangiography (ERC) or an endoscopic retrograde cholangiopancreatography (ERCP) - introduced an X-ray contrast agent under X-ray control in the duct system to be examined.
- ERP endoscopic retrograde cholangiography
- ERCP endoscopic retrograde cholangiopancreatography
- X-ray contrast agents are agents for improving the radiographic representation of body spaces, hollow organs and vessels. They absorb X-rays either weaker (negative X-ray contrast agents) or stronger (positive X-ray contrast agents) than the surrounding body tissue.
- the radiopaque (i.e., radiopaque) positive X-ray contrast agents contain predominantly high atomic number elements (such as iodine and barium) because their X-ray absorptivity is greater.
- organic iodine derivatives derived from pyridines or aromatic carboxylic acids are typically used.
- iodoxamic acid [3,3 '- (4,7,10,13-tetraoxahexadecanedioyldiamino) -bis (2,4,6-triiodobenzoic acid)] and [3,3' - (3,6,9-trioxaundecanedioyldiamino)] bis (2,4,6-trüodbenzoeklare)].
- Endoscopies mostly take place in microbially colonized areas of the body.
- a transmission of pathogens by contaminated endoscopy itself and by endoscopic accessories has been proven many times.
- infections with a long incubation period are very difficult and usually impossible to detect in practice.
- patients whose illness is dumb or unrecognized come into contact with endoscopes.
- infections with microorganisms whose transmission takes place through the blood and mucous membranes, such.
- tuberculosis hepatitis, HIV infections, salmonellosis, Yersinia infections, dysentery and the like.
- liquid cleaning agents for cleaning of flexible endoscopes which contain surfactants in addition to essentially organic solvents, acids or alkalis, and sometimes also enzymes.
- surfactants in addition to essentially organic solvents, acids or alkalis, and sometimes also enzymes.
- the compounds mentioned have some disadvantages:
- liquid cleaners are relatively effective at removing blood and secretion residues as well as at the separation of fat and other hydrocarbonaceous compounds. However, they are not suitable for completely removing residues of X-ray contrast agents.
- the object of the invention is therefore to develop a liquid cleaning agent for the removal of X-ray contrast agents, which does not have the disadvantages of the prior art, which thus shows a good cleaning performance at the same time high material compatibility and also for the removal of X-ray contrast agents, such.
- X-ray contrast agents such as organic, aromatic iodine derivatives, in particular from flexible endoscopes.
- cleaning agents also dried on sparingly soluble aromatic halogen compounds such.
- the use of the cleaning agent according to the invention especially in duoendoscopes over which X-ray contrast agents are preferably administered, has a significantly better cleaning performance than the cleaners of the prior art. This greatly improved the microbiological status of duoendoscopes (after subsequent disinfection).
- the nonionic surfactant or surfactants are selected from the group of alkylethoxylates whose alkyl group is a saturated or unsaturated, straight or branched chain alkyl group having 10 to 18, preferably 12 to 14 carbon atoms, preferably 2 to 15, in particular 5 to 9, per molecule , especially containing 7 ethylene oxide units.
- alkylethoxylates whose alkyl group is a saturated or unsaturated, straight or branched chain alkyl group having 10 to 18, preferably 12 to 14 carbon atoms, preferably 2 to 15, in particular 5 to 9, per molecule , especially containing 7 ethylene oxide units.
- isotridecanol ethoxylate and / or fatty alcohol polyglycol ethers are particularly preference.
- the total amount of nonionic surfactants is selected from the range of 1.0 to 20.0 wt .-%, preferably from 10.0 to 15.0 wt .-%, each based on the total weight of preparations.
- the pyrrolidonecarboxylic acid (pyroglutamic acid), which is characterized by the following structural formula: used.
- the total amount of the amino acid is selected from the range of 0.1 to 10.0 wt .-%, preferably from 0.5 to 2.0 wt .-%, each based on the total weight of the preparations.
- the cleaning agents used according to the invention can be further Amphoteric surfactants included.
- Amphoteric surfactants are surfactants that possess both acidic and basic hydrophilic groups and thus behave acidic or basic depending on the condition.
- amphoteric surfactants based on aliphatic polyamines having carboxy, sulfo or phosphono side chains, for example R-NH- (CH 2 ) n -COOH are advantageous.
- amphoteric surfactants whose alkyl group is a saturated or unsaturated, straight or branched chain alkyl group having 10 to 18, preferably 12 to 14 carbon atoms.
- amphoteric surfactants from the group of amphopropionates such as. Cocobetainamido amphopropionate, which is characterized by the following structure:
- the total amount of amphoteric surfactants is selected from the range of 1.0 to 10.0 wt .-%, preferably from 2.0 to 5.0 wt .-%, each based on the total weight of the preparations ,
- the detergents used according to the invention can be in the form of liquid concentrates and packaged, for example, in dosing bags, so that a use solution can be prepared fresh in each case. It is particularly advantageous if the pH of the concentrate is between 5 and 9.
- the liquid concentrates are preferably diluted with water to a use solution. Preference is given to the use of working solutions containing 0.5 to 5 wt .-% of cleaning agent according to the invention.
- the use solution preferably has a pH between 6 and 8 in order to achieve optimal protection of the sensitive material.
- the cleaning agents used according to the invention can also advantageously contain conventional corrosion inhibitors, such as, for example, benzotriazole, in particular if they can come into contact with metallic surfaces, in particular with non-refined steels or materials of non-ferrous metal alloys, when used. It is preferred to choose the content of one or more corrosion inhibitors between 0.1 and 5 wt .-%, based on the total weight of the formulation.
- conventional corrosion inhibitors such as, for example, benzotriazole
- the cleaning agents used according to the invention may advantageously additionally contain complexing agents and / or pH regulators in order to reduce the negative influence of fluctuating water hardness or to ensure that the pH of the cleaning agent is within a range which does not damage the sensitive material.
- the cleaning agents used according to the invention for such preparations may contain customary preservatives, dyes, fragrances and / or other customary auxiliaries. These contribute in the majority of cases not to the cleaning effect, but serve the storage and aesthetic purposes. However, it is also possible to use those components which develop a (preservative, nourishing effect and at the same time provide for a particular color and / or a pleasant fragrance.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Detergent Compositions (AREA)
Abstract
Description
Die vorliegende Erfindung betrifft die Verwendung von flüssigen Reinigungsmittel mit einem Gehalt an Tensiden, Korrosionsschutzmitteln und weiteren Zusätzen, die die Reinigung verstärken zur Reinigung von medizinischen Instrumenten, insbesondere zur Reinigung von flexiblen Endoskopen durch Entfernung von Röntgenkontrastmitteln.The present invention relates to the use of liquid detergents containing surfactants, corrosion inhibitors and other additives that enhance cleaning for cleaning medical instruments, in particular for cleaning flexible endoscopes by removing X-ray contrast agents.
Endoskope sind röhren- oder schlauchförmige Instrumente, welche zur Untersuchung von Körperhohlräumen und Hohlorganen verwendet werden. Sie sind mit einem optischen System, bestehend aus Objektiv und Okular, einer Beleuchtungseinrichtung und meist Spül- und Absaugvorrichtungen sowie Kanälen zum Einführen spezieller Instrumente ausgestattet. Flexible Endoskope (welche auch als Fiberendoskope bezeichnet werden) sind mit einem Glasfaserlichtleiter ausgerüstet, welcher aus einem dicht gepackten Bündel aus haarfeinen und deshalb hochflexiblen Einzelfasern besteht. Durch die Flexibilität der Glasfasern können Licht und Bild über praktisch jede beliebige Abwinklung übertragen werden. Zusätzlich zu den Faserbündeln und den Bowdenzügen für die Bewegung der Spitze sind Kanäle für Wasserspülung und Luft sowie ein in der Regel größerer Biopsie- und gleichzeitig Absaugkanal untergebracht.Endoscopes are tubular or tubular instruments used to examine body cavities and hollow organs. They are equipped with an optical system consisting of lens and eyepiece, a lighting device and usually rinsing and suction devices and channels for introducing special instruments. Flexible endoscopes (which are also referred to as fiber endoscopes) are equipped with a fiber optic light guide, which consists of a tightly packed bundle of hair-thin and therefore highly flexible individual fibers. Due to the flexibility of the glass fibers, light and image can be transmitted via virtually any bend. In addition to the fiber bundles and the Bowden cables for the movement of the tip channels for flushing and air and a generally larger biopsy and at the same time suction duct are housed.
Die Endoskopie kann allein, beispielsweise zur Entnahme von Gewebeproben, aber auch in Kombination mit weiteren Methoden, wie z. B. der Ultraschalldiagnostik (Endosonographie) oder der Röntgendiagnostik durchgeführt werden. Gebräuchlich sind beispielsweise Röntgenkontrastdarstellungen der Gallenblase und der Gallengänge sowie des Pankreasgangsystems. Hierbei wird - z. B. im Rahmen einer endoskopischen retrograden Cholangiographie (ERC) bzw. einer endoskopischen retrograden Cholangiopankreatikographie (ERCP) - ein Röntgenkontrastmittel unter Röntgenkontrolle in das zu untersuchende Gangsystem eingebracht.The endoscopy alone, for example, for the removal of tissue samples, but also in combination with other methods, such. As the ultrasound (endoscopic ultrasonography) or X-ray diagnostics are performed. For example, X-ray contrast images of the gallbladder and the bile ducts and of the pancreatic duct system are commonly used. This is -. B. in the context of an endoscopic retrograde cholangiography (ERC) or an endoscopic retrograde cholangiopancreatography (ERCP) - introduced an X-ray contrast agent under X-ray control in the duct system to be examined.
Röntgenköntrastmittel sind Mittel zur Verbesserung der röntgenographischen Darstellung von Körperräumen, Hohlorganen und Gefäßen. Sie absorbieren Röntgenstrahlung entweder schwächer (negative Röntgenkontrastmittel) oder stärker (positive Röntgenkontrastmittel) als das umgebende Körpergewebe. Die radioopaken (d. h. strahlungsundurchlässigen) positiven Röntgenkontrastmittel enthalten vorwiegend Elemente hoher Ordnungszahlen (wie lod und Barium), da deren Absorptionsvermögen für Röntgenstrahlen größer ist. Für die Cholangiographie werden in der Regel organische lod-Derivate, die sich von Pyridinen oder aromatischen Carbonsäuren ableiten, verwendet. Beispiele hierfür sind lodoxaminsäure [3,3'-(4,7,10,13-Tetraoxahexadecandioyldiamino)-bis(2,4,6-triiodbenzoesäure)] und lotroxinsäure [3,3'-(3,6,9-Trioxaundecandioyldiamino)bis(2,4,6-trüodbenzoesäure)].X-ray contrast agents are agents for improving the radiographic representation of body spaces, hollow organs and vessels. They absorb X-rays either weaker (negative X-ray contrast agents) or stronger (positive X-ray contrast agents) than the surrounding body tissue. The radiopaque (i.e., radiopaque) positive X-ray contrast agents contain predominantly high atomic number elements (such as iodine and barium) because their X-ray absorptivity is greater. For cholangiography, organic iodine derivatives derived from pyridines or aromatic carboxylic acids are typically used. Examples of these are iodoxamic acid [3,3 '- (4,7,10,13-tetraoxahexadecanedioyldiamino) -bis (2,4,6-triiodobenzoic acid)] and [3,3' - (3,6,9-trioxaundecanedioyldiamino)] bis (2,4,6-trüodbenzoesäure)].
Endoskopien finden zum Großteil in mikrobiell besiedelten Körperbereichen statt. Die Anzahl endoskopischer Untersuchungen des oberen und unteren Gastrointestinaltraktes und des Tracheobronchialsystems, häufig verbunden mit invasiven Eingriffen, ist sehr hoch. Eine Übertragung von Krankheitserregern durch kontaminierte Endoskopien selbst und durch endoskopisches Zubehör konnte vielfach belegt werden.Endoscopies mostly take place in microbially colonized areas of the body. The number of endoscopic examinations of the upper and lower gastrointestinal tract and the tracheobronchial system, often associated with invasive procedures, is very high. A transmission of pathogens by contaminated endoscopy itself and by endoscopic accessories has been proven many times.
Aus dem Stand der Technik sind die Probleme bei der Reinigung und Desinfektion von Kathetern und Endoskopen bekannt. So beschreibt A. Beck ("Wiederaufbereitung? Untersuchungen zur Wiederverwendung von Kathetern, Führungsdrähten und Angio-Endoskopen", Schnitztor-Verlag GmbH, Konstanz, 1993, 110 - 114) die Schwierigkeiten bezüglich einer ausreichenden Reinigung solcher medizinischer Instrumente aufgrund von abgelagerten Blutbestandteilen und verkrustetem Kontrastmittel.From the prior art, the problems in the cleaning and disinfection of catheters and endoscopes are known. Thus, A. Beck ( "Wiederaufbereitung - Investigations on the reuse of catheters, guidewires and angio-endoscopes", Schnitzor-Verlag GmbH, Konstanz, 1993, 110-114) describes the difficulties with regard to sufficient cleaning of such medical instruments due to deposited blood components and encrusted contrast agent.
Insbesondere Infektionen mit langer Inkubationszeit sind nur sehr schwer und in der Praxis meist gar nicht zu erfassen. Ferner muß damit gerechnet werden, daß auch Patienten, deren Erkrankung stumm oder unerkannt ist, mit Endoskopen in Berührung kommen. Besonderes Gewicht haben in diesem Zusammenhang Infektionen mit Mikroorganismen, deren Übertragung durch das Blut und über die Schleimhäute erfolgt, wie z. B. Tuberkulose, Hepatitis, HIV-Infektionen, Salmonellose, Yersinien-Infektionen, Ruhr und dergleichen mehr.In particular, infections with a long incubation period are very difficult and usually impossible to detect in practice. Furthermore, it must be expected that even patients whose illness is dumb or unrecognized come into contact with endoscopes. Of particular importance in this context are infections with microorganisms whose transmission takes place through the blood and mucous membranes, such. As tuberculosis, hepatitis, HIV infections, salmonellosis, Yersinia infections, dysentery and the like.
Eine Anforderung an die Endoskopie sollte daher die uneingeschränkte Einhaltung aller erforderlichen Schutzmaßnahmen zur Infektionsverhütung sein. Allerdings war die Reinigung und Desinfektion der Fiberendoskope lange Zeit ein Stiefkind der technologischen Entwicklung. So gibt es beispielsweise Probleme mit Restwasser und entsprechender bakterieller Fehlbesiedlung, darüberhinaus lassen sich Endoskope nur schwer trocknen.A requirement for endoscopy should therefore be full compliance with all necessary preventive measures for infection prevention. However, the cleaning and disinfection of fiber endoscopes has long been a stepchild of technological development. For example, there are problems with residual water and corresponding bacterial incorrect colonization, moreover, endoscopes are difficult to dry.
Im Stand der Technik sind z.B. eine Vielzahl von Reinigungs- und Desinfektionsmitteln auf Basis von Glucoprotamin zur Reinigung medizinischer Instrumente beschrieben.In the prior art, e.g. a variety of cleaning and disinfecting agents based on glucoprotamine for cleaning medical instruments described.
So beschreiben
Ein weiteres Glucoprotamin- und Tensid-haltiges Mittel zur Instrumentendesinfektion und -reinigung ist in einer Broschüre der Firma Henkel zu dem Produkt "Sekusept®Plus", veröffentlicht im Oktober 1992, beschrieben.Another glucoprotamin- and surfactant-containing agent for instrument disinfection and cleaning is described in a brochure from Henkel on the product "Sekusept®Plus", published in October 1992.
Neben Glucoprotamin-basierten Reinigungs- und Desinfektionsmitteln kennt der Stand der Technik zur Reinigung von Gegenständen aus medizinischen Einrichtungen, wie medizinische Instrumente, solche auf Basis anderer Wirkstoffe. In der Patentanmeldung
Daher muß im Vorfeld einer endoskopischen Untersuchung nicht nur die Übertragung von Mikroorganismen, die von Patienten stammen, verhindert werden, sondern es sollte ferner ein besonderes Augenmerk auf Krankheitserreger aus Spülwasser oder stagnierendem Wasser gerichtet werden.Therefore, in advance of an endoscopic examination, not only the transmission of microorganisms derived from patients must be prevented, but also a special attention should be paid to pathogens from rinsing water or stagnant water.
Der Stand der Technik kennt flüssige Reinigungsmittel zur Reinigung von flexiblen Endoskopen, welche neben Tensiden im wesentlichen organische Lösemittel, Säuren oder Laugen sowie teilweise auch Enzyme enthalten. Allerdings weisen die genannten Verbindungen einige Nachteile auf:The prior art knows liquid cleaning agents for cleaning of flexible endoscopes, which contain surfactants in addition to essentially organic solvents, acids or alkalis, and sometimes also enzymes. However, the compounds mentioned have some disadvantages:
Lösemittel, Säuren und Laugen sind zwar von ihrer Wirksamkeit her zur Reinigung prinzipiell geeignet, haben aber den Nachteil, daß sie für das empfindliche Material zu aggressiv sind und die Endoskope dementsprechend beschädigen können.Although solvents, acids and alkalis are in principle suitable for their effectiveness for cleaning, but have the disadvantage that they are too aggressive for the sensitive material and can damage the endoscope accordingly.
Der Umgang mit enzymhaltigen Reinigern ist aus Arbeitssicherheitsgründen problematisch, da diese als sensibilisierende Stoffe und dementsprechend gesundheitsschädlich eingestuft werden, weshalb z. B. Berührungen mit der Haut vermieden werden sollten.The handling of enzyme-containing cleaners is problematic for safety reasons, since these are classified as sensitizing substances and accordingly harmful to health, which is why z. B. Skin contact should be avoided.
Die flüssigen Reinigungsmittel des Standes der Technik sind bei der Entfernung von Blut- und Sekretresten sowie bei der Ablösung von Fett und anderen kohlenwasserstoffhaltigen Verbindungen relativ gut wirksam. Allerdings eignen sie sich nicht, um Reste von Röntgenkontrastmitteln vollständig zu entfernen.The prior art liquid cleaners are relatively effective at removing blood and secretion residues as well as at the separation of fat and other hydrocarbonaceous compounds. However, they are not suitable for completely removing residues of X-ray contrast agents.
Bereits geringste Mengen zurückgebliebenes Röntgenkontrastmittel schließen Bakterien in den Endoskopkanälen ein, die mit den üblichen Desinfektionsmitteln dann nicht mehr vollständig beseitigt werden können. Bei regelmäßigem Einsatz flexibler Endoskope in der Praxis baut sich so im Laufe der Zeit auf der Innenseite der Kanäle ein zunehmender Film des Röntgenkontrastmittels und weiterer Rückstände auf, was zur Folge haben kann, daß das mikrobiologische Ergebnis selbst nach der an die Reinigung anschließenden Desinfektion nicht mehr befriedigend ist.Even the smallest amounts of remaining X-ray contrast media include bacteria in the endoscope channels, which can then no longer be completely eliminated with the usual disinfectants. With regular use of flexible endoscopes in practice builds up over time on the inside of the channels an increasing film of the X-ray contrast agent and other residues, which may result in that the microbiological result is no longer satisfactory, even after the disinfection subsequent to the cleaning.
Für die Patienten bedeutet dies ein erhöhtes Infektionsrisiko und stellt dementsprechend eine erhebliche Gefährdung dar. Zum Schutz vor Infektionen bleibt dann nur noch die Möglichkeit einer Reparatur, was zum einen aufwendig und zum anderen teuer ist.For the patients, this means an increased risk of infection and therefore represents a significant threat. To protect against infection then remains only the possibility of repair, which is both expensive and expensive.
Aufgabe der Erfindung war es daher, ein flüssiges Reinigungsmittel zur Entfernung von Röntgenkontrastmitteln zu entwickeln, das die Nachteile des Standes der Technik nicht aufweist, welches also eine gute Reinigungsleistung bei zugleich hoher Materialverträglichkeit zeigt und sich auch zur Entfernung von Röntgenkontrastmitteln, wie z. B. organischen, aromatischen lod-Derivaten, insbesondere aus flexiblen Endoskopen eignet.The object of the invention is therefore to develop a liquid cleaning agent for the removal of X-ray contrast agents, which does not have the disadvantages of the prior art, which thus shows a good cleaning performance at the same time high material compatibility and also for the removal of X-ray contrast agents, such. As organic, aromatic iodine derivatives, in particular from flexible endoscopes.
Es wurde nun überraschend gefunden, daß alle diese Aufgaben gelöst werden durch die Verwendung von flüssigen Reinigungsmitteln, welche
- ■ mindestens ein nichtionisches Tensid und
- ■ Pyrrolidoncarbonsäure
- ■ at least one nonionic surfactant and
- ■ pyrrolidonecarboxylic acid
Es war insbesondere überraschend, daß die erfindungsgemäß verwendeten Reinigungsmittel besser und schonender reinigen als die Zubereitungen des Standes der Technik und daß durch diese verbesserte Reinigung bei den überprüften flexiblen Endoskopen das mikrobiologische Problem des Standes der Technik wesentlich verringert werden konnte.It was particularly surprising that the cleaning agents used according to the invention clean better and more gently than the preparations of the prior art and that the microbiological problem of the prior art could be substantially reduced by this improved cleaning in the tested flexible endoscopes.
Erstaunlicherweise lassen sich durch die erfindungsgemäße Verwendung der Reinigungsmittel auch angetrocknete schwerlösliche aromatische Halogenverbindungen, wie z. B. Röntgenkontrastmittelrückstände, vollständig von den Oberflächen ablösen. Durch die erfindungsgemäß Verwendung des Reinigungsmittel sind flexible Endoskope auch nach Monaten ständigen Einsatzes in der Praxis mikrobiologisch immer noch einwandfrei. Dadurch wird die Sicherheit der Patienten wesentlich erhöht und die Lebensdauer dieser hochwertigen medizinischen Geräte verlängert.Surprisingly, by the inventive use of cleaning agents also dried on sparingly soluble aromatic halogen compounds such. B. X-ray contrast agent residues, completely detach from the surfaces. Due to the use of the cleaning agent according to the invention, flexible endoscopes are still microbiologically immaculate even after months of constant use in practice. This significantly increases patient safety and extends the life of these high quality medical devices.
So konnte beispielsweise nachgewiesen werden, daß die erfindungsgemäß Verwendung des Reinigungsmittel besonders bei Duoendoskopen, über die Röntgenkontrastmittel bevorzugt verabreicht werden, eine im Vergleich zu den Reinigern des Standes der Technik wesentlich bessere Reinigungsleistung haben. Hierdurch konnte der mikrobiologische Status der Duoendoskope (nach anschließender Desinfektion) stark verbessert werden.For example, it has been demonstrated that the use of the cleaning agent according to the invention, especially in duoendoscopes over which X-ray contrast agents are preferably administered, has a significantly better cleaning performance than the cleaners of the prior art. This greatly improved the microbiological status of duoendoscopes (after subsequent disinfection).
Erfindungsgemäß vorteilhaft werden das oder die nichtionische Tenside gewählt aus der Gruppe der Alkylethoxylate, deren Alkylgruppe eine gesättigte oder ungesättigte, geradoder verzweigtkettige Alkylgruppe mit 10 bis 18, vorzugsweise 12 bis 14 Kohlenstoffatomen ist, wobei sie vorzugsweise pro Molekül 2 bis 15, insbesondere 5 bis 9, speziell 7 Ethylenoxideinheiten enthalten. Ganz besonders bevorzugt sind Isotridecanolethoxylat und/oder Fettalkoholpolyglykolether.According to the invention, the nonionic surfactant or surfactants are selected from the group of alkylethoxylates whose alkyl group is a saturated or unsaturated, straight or branched chain alkyl group having 10 to 18, preferably 12 to 14 carbon atoms, preferably 2 to 15, in particular 5 to 9, per molecule , especially containing 7 ethylene oxide units. Very particular preference is given to isotridecanol ethoxylate and / or fatty alcohol polyglycol ethers.
Vorteilhaft wird die Gesamtmenge an nichtionischen Tensiden (eine oder mehrere Verbindungen) aus dem Bereich von 1,0 bis 20,0 Gew.-%, vorzugsweise von 10,0 bis 15,0 Gew.-% gewählt, jeweils bezogen auf das Gesamtgewicht der Zubereitungen.Advantageously, the total amount of nonionic surfactants (one or more compounds) is selected from the range of 1.0 to 20.0 wt .-%, preferably from 10.0 to 15.0 wt .-%, each based on the total weight of preparations.
Erfindungsgemäß wird die Pyrrolidoncarbonsäure (Pyroglutaminsäure), welche sich durch die folgende Strukturformel auszeichnet:
Vorteilhaft wird die Gesamtmenge der Aminosäure aus dem Bereich von 0,1 bis 10,0 Gew.-%, vorzugsweise von 0,5 bis 2,0 Gew.-% gewählt, jeweils bezogen auf das Gesamtgewicht der Zubereitungen.Advantageously, the total amount of the amino acid is selected from the range of 0.1 to 10.0 wt .-%, preferably from 0.5 to 2.0 wt .-%, each based on the total weight of the preparations.
In einer besonders vorteilhaften Ausführungsform können die erfindungsgemäß verwendeten Reinigungsmittel ferner Amphotenside enthalten. Amphotenside sind Tenside, die sowohl saure als auch basische hydrophile Gruppen besitzen und sich also je nach Bedingung sauer oder basisch verhalten. Vorteilhaft im Sinne der vorliegenden Erfindung sind beispielsweise Amphotenside auf der Basis von aliphatischen Polyaminen mit Carboxy-, Sulfo- oder Phosphono-Seitenketten, wie beispielsweise R-NH-(CH2)n-COOH.In a particularly advantageous embodiment, the cleaning agents used according to the invention can be further Amphoteric surfactants included. Amphoteric surfactants are surfactants that possess both acidic and basic hydrophilic groups and thus behave acidic or basic depending on the condition. For the purposes of the present invention, for example, amphoteric surfactants based on aliphatic polyamines having carboxy, sulfo or phosphono side chains, for example R-NH- (CH 2 ) n -COOH, are advantageous.
Erfindungsgemäß bevorzugt sind z. B. Amphotenside, deren Alkylgruppe eine gesättigte oder ungesättigte, gerad- oder verzweigtkettige Alkylgruppe mit 10 bis 18, vorzugsweise 12 bis 14 Kohlenstoffatomen ist.According to the invention are preferred z. As amphoteric surfactants whose alkyl group is a saturated or unsaturated, straight or branched chain alkyl group having 10 to 18, preferably 12 to 14 carbon atoms.
Insbesondere vorteilhaft sind ferner Amphotenside aus der Gruppe der Amphopropionate, wie z. B. das Cocobetainamido Amphopropionat, welches sich durch die folgende Struktur auszeichnet:
Vorteilhaft wird die Gesamtmenge an Amphotensiden (eine oder mehrere Verbindungen) aus dem Bereich von 1,0 bis 10,0 Gew.-%, vorzugsweise von 2,0 bis 5,0 Gew.-% gewählt, jeweils bezogen auf das Gesamtgewicht der Zubereitungen.Advantageously, the total amount of amphoteric surfactants (one or more compounds) is selected from the range of 1.0 to 10.0 wt .-%, preferably from 2.0 to 5.0 wt .-%, each based on the total weight of the preparations ,
Die erfindungsgemäß verwendeten Reinigungsmittel können in Form von flüssigen Konzentraten vorliegen und beispielsweise in Dosierbeutel abgepackt werden, so daß eine Gebrauchslösung jeweils frisch angesetzt werden kann. Es ist insbesondere vorteilhaft, wenn der pH-Wert des Konzentrates zwischen 5 und 9 liegt. Die flüssigen Konzentrate werden vorzugsweise mit Wasser zu einer Gebrauchslösung verdünnt. Bevorzugt ist die Verwendung von Gebrauchslösungen, die 0,5 bis 5 Gew.-% an erfindungsgemäßen Reinigungsmittel enthalten. Die Gebrauchslösung hat vorzugsweise einen pH-Wert zwischen 6 und 8, um eine optimale Schonung des empfindlichen Materials zu erreichen.The detergents used according to the invention can be in the form of liquid concentrates and packaged, for example, in dosing bags, so that a use solution can be prepared fresh in each case. It is particularly advantageous if the pH of the concentrate is between 5 and 9. The liquid concentrates are preferably diluted with water to a use solution. Preference is given to the use of working solutions containing 0.5 to 5 wt .-% of cleaning agent according to the invention. The use solution preferably has a pH between 6 and 8 in order to achieve optimal protection of the sensitive material.
Vorteilhaft ist es, die Verdünnung so durchzuführen, daß der Gehalt der einzelnen Substanzen in der Gebrauchslösung wie folgt ist:
- ■ nichtionische Tenside: zwischen 0,005 und 1 Gew.-%
- ■ Aminosäure: zwischen 0,0005 und 0,5 Gew.-%
- ■ Amphotenside: zwischen 0,005 und 0,5 Gew.-%
- ■ nonionic surfactants: between 0.005 and 1% by weight
- ■ Amino acid: between 0.0005 and 0.5 wt .-%
- Amphoteric surfactants: between 0.005 and 0.5% by weight
Die erfindungsgemäß verwendeten Reinigungsmittel können ferner vorteilhaft zusätzlich übliche Korrosionsinhibitoren, wie beispielsweise Benzotriazol, enthalten, insbesondere falls sie bei ihrer Anwendung mit metallischen Oberflächen, insbesondere mit nicht veredelten Stählen oder Werkstoffen aus Buntmetallegierungen, in Berührung kommen können. Es wird bevorzugt, den Gehalt an einem oder mehreren Korrosionsinhibitoren zwischen 0,1 und 5 Gew.-%, bezogen auf das Gesamtgewicht der Formulierung, zu wählen.The cleaning agents used according to the invention can also advantageously contain conventional corrosion inhibitors, such as, for example, benzotriazole, in particular if they can come into contact with metallic surfaces, in particular with non-refined steels or materials of non-ferrous metal alloys, when used. It is preferred to choose the content of one or more corrosion inhibitors between 0.1 and 5 wt .-%, based on the total weight of the formulation.
Die erfindungsgemäß verwendeten Reinigungsmittel können darüberhinaus vorteilhaft zusätzlich Komplexbildner und/oder pH-Regulatoren enthalten, um den negativen Einfluß schwankender Wasserhärte zu reduzieren bzw. um zu gewährleisten, daß der pH-Wert des Reinigungsmittels in einem Bereich liegt, der das empfindliche Material nicht schädigt.In addition, the cleaning agents used according to the invention may advantageously additionally contain complexing agents and / or pH regulators in order to reduce the negative influence of fluctuating water hardness or to ensure that the pH of the cleaning agent is within a range which does not damage the sensitive material.
Zusätzlich zu den vorstehend genannten Komponenten können die erfindungsgemäß verwendeten Reinigungsmittel für derartige Zubereitungen übliche Konservierungsstoffe, Farbstoffe, Duftstoffe und/oder andere übliche Hilfsstoffe enthalten. Diese tragen in der Mehrzahl der Fälle nicht zur reinigenden Wirkung bei, sondern dienen der Lagerbarkeit sowie ästhetischen Zwecken. Es ist jedoch auch möglich, solche Komponenten zu verwenden, die eine (konservierende, pflegende Wirkung entfalten und dabei gleichzeitig für eine bestimmte Farbe und/oder einen angenehmen Duft sorgen.In addition to the abovementioned components, the cleaning agents used according to the invention for such preparations may contain customary preservatives, dyes, fragrances and / or other customary auxiliaries. These contribute in the majority of cases not to the cleaning effect, but serve the storage and aesthetic purposes. However, it is also possible to use those components which develop a (preservative, nourishing effect and at the same time provide for a particular color and / or a pleasant fragrance.
Die jeweils einzusetzenden Mengen an derartigen Trägerstoffen und Parfüm können in Abhängigkeit von der Art des jeweiligen Produktes vom Fachmann durch einfaches Ausprobieren leicht ermittelt werden.The amounts of such carriers and perfume to be used in each case can easily be determined by the skilled person by simple trial and error, depending on the nature of the particular product.
Die folgenden Beispiele dienen dazu, die Erfindung zu beschreiben, selbstverständlich ohne daß beabsichtigt ist, die Erfindung auf diese Beispiele zu beschränken. Alle Mengenangaben, Anteile und Prozentanteile sind, soweit nicht anders angegeben, auf das Gewicht und die Gesamtmenge bzw. auf das Gesamtgewicht der Zubereitungen bezogen.The following examples serve to describe the invention, of course, without intending to limit the invention to these examples. All amounts, proportions and percentages are, unless otherwise stated, on the weight and the total amount or on the total weight of the preparations based.
Es wird ein pH-Wert von 8 eingestellt.It is set to a pH of 8.
Es wird ein pH-Wert von 8 eingestellt.It is set to a pH of 8.
Es wird ein pH-Wert von 8 eingestellt.It is set to a pH of 8.
Mit einem flüssigen Reinigungsmittel gemäß Beispielrezeptur 3 wurde ein Anwendungstest durchgeführt. Dazu wurden 129 Duoendoskope mit einem Reinigungsmittel des Standes der Technik (enzymatischer Reiniger) und 97 Duoendoskope mit dem erfindungsgemäß zu verwenden dem Reinigungsmittel jeweils gereinigt und anschließend desinfiziert; danach wurde der mikrobiologische Status der Geräte überprüft. Es ergaben sich die folgenden Ergebnisse:
2 Reinigungsmittel gemäß Beispielrezeptur 3
2 detergent according to example recipe 3
Claims (10)
- Use of liquid cleaners that contain at least one nonionic surfactant and pyrrolidone carboxylic acid, for the cleaning of medical instruments, flexible endoscopes and surfaces in medical use, by removing X-ray contrast enhancing agents.
- Use in accordance with Claim 1, characterised in that the nonionic surfactant or surfactants is, or are chosen from a group of alkyl ethoxylates with an alkyl group that is a saturated or unsaturated, straight or branched chain alkyl group with 10 to 18, preferably 12 carbon atoms.
- Use in accordance with one of claims 1 or 2, characterised in that the cleaner contains isotridecanol ethoxylate and/or fatty alcohol polyglycol ether.
- Use in accordance with one of claims 1 or 3, characterised in that the cleaner contains at least one ampho-surfactant(s) as (a) further contituent(s).
- Use in accordance with Claim 4, characterised in that the nonionic surfactant or surfactants is, or are chosen from the group of ampho-surfactants with an alkyl group that is a saturated or unsaturated, straight or branched chain alkyl group with 10 to 18, preferably 12 carbon atoms.
- Use in accordance with one of claims 4 or 5, characterised in that it contains cocoamido betain ampho-proprionate as the ampho-surfactant
- Use in accordance with one of claims 4 to 6, characterised in that the quantity of ampho-surfactant (one or several compounds) is chosen from the range of 1.0 to 10.0 % w/w, preferably 2.0 to 5% w/w, in each case relative to the total weight of the preparations.
- Use in accordance with one of claims 1 to 7, characterised in that the cleaner contains one or several nonionic surfactants in a quantity of 1.0 to 20.0 % w/w, preferably 10.0 to 15% w/w, in each case relative to the total weight of the preparations.
- Use in accordance with one of claims 1 to 8, characterised in that the cleaner contains pyrrolidone carboxylic acid in a quantity of 0.1 to 10.0 % w/w, in each case relative to the total weight of the preparations.
- Use in accordance with one of claims 1 to 9, characterised in that the cleaner is provided in the form of a concentrate which is diluted with water before use as a working solution.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10007323 | 2000-02-17 | ||
DE10007323A DE10007323A1 (en) | 2000-02-17 | 2000-02-17 | Detergent for medical instruments |
Publications (3)
Publication Number | Publication Date |
---|---|
EP1126013A1 EP1126013A1 (en) | 2001-08-22 |
EP1126013B1 EP1126013B1 (en) | 2005-01-19 |
EP1126013B2 true EP1126013B2 (en) | 2013-03-27 |
Family
ID=7631356
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP01100242A Expired - Lifetime EP1126013B2 (en) | 2000-02-17 | 2001-01-03 | Cleaning composition for medical devices |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1126013B2 (en) |
AT (1) | ATE287442T1 (en) |
DE (2) | DE10007323A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102014003484A1 (en) | 2014-03-14 | 2015-09-17 | Bode Chemie Gmbh | Cleaner for inanimate surfaces with special effectiveness against mucus, secretions, blood and biofilms |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0156275A2 (en) † | 1984-03-24 | 1985-10-02 | Henkel Kommanditgesellschaft auf Aktien | Antimicrobially active substances, their preparation and their use |
WO1997028829A1 (en) † | 1996-02-05 | 1997-08-14 | Henkel-Ecolab Gmbh & Co. Ohg | Process for cleaning and disinfecting sensitive medical instruments |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4007758A1 (en) * | 1990-03-12 | 1991-09-19 | Henkel Kgaa | MEANS AND METHODS FOR CLEANING AND DISINFECTING OBJECTS FROM MEDICAL EQUIPMENT IN AUTOMATED EQUIPMENT |
DE4234070A1 (en) * | 1992-10-09 | 1994-04-14 | Henkel Ecolab Gmbh & Co Ohg | Cleaning disinfectant |
DE4324396A1 (en) * | 1993-07-21 | 1995-01-26 | Henkel Kgaa | Detergents with high wettability |
JP3686434B2 (en) * | 1993-10-01 | 2005-08-24 | 千寿製薬株式会社 | Stabilizing method for contact lenses |
JPH0812572A (en) * | 1994-07-01 | 1996-01-16 | Kosakai:Kk | Therapeutic agent for dermatomycosis |
DE4433071C1 (en) * | 1994-09-16 | 1995-12-21 | Henkel Kgaa | Mild detergent mixtures |
US5576284A (en) * | 1994-09-26 | 1996-11-19 | Henkel Kommanditgesellschaft Auf Aktien | Disinfecting cleanser for hard surfaces |
GB9501285D0 (en) * | 1995-01-24 | 1995-03-15 | Jeyes Group Plc | Cleansing compositions |
GB2321252A (en) * | 1997-01-16 | 1998-07-22 | Reckitt & Colman Inc | Carpet cleaning compositions |
ATE262575T1 (en) * | 1997-03-12 | 2004-04-15 | Showa Denko Kk | CLEANING SUPPLIES |
JP4104704B2 (en) * | 1997-10-01 | 2008-06-18 | シスメックス株式会社 | Cleaning agent for automatic analyzer |
JP4061420B2 (en) * | 1998-07-03 | 2008-03-19 | 昭和電工株式会社 | Liquid detergent composition |
-
2000
- 2000-02-17 DE DE10007323A patent/DE10007323A1/en not_active Withdrawn
-
2001
- 2001-01-03 AT AT01100242T patent/ATE287442T1/en active
- 2001-01-03 DE DE50105092T patent/DE50105092D1/en not_active Expired - Lifetime
- 2001-01-03 EP EP01100242A patent/EP1126013B2/en not_active Expired - Lifetime
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0156275A2 (en) † | 1984-03-24 | 1985-10-02 | Henkel Kommanditgesellschaft auf Aktien | Antimicrobially active substances, their preparation and their use |
WO1997028829A1 (en) † | 1996-02-05 | 1997-08-14 | Henkel-Ecolab Gmbh & Co. Ohg | Process for cleaning and disinfecting sensitive medical instruments |
Non-Patent Citations (2)
Title |
---|
"Sekusept Plus-Pluspunkte über pluspunkte in der instrumenten-desinfektion", HENKEL HYGIENE GMBH GV-PHARMADIENST, 1 October 1992 (1992-10-01), DÜSSELDORF, pages 1 - 4 † |
MEYER B. ET ALL: "Efficacy of glucoprotamin containing disinfectants against different species of atypical mycobacteria", HOSPITAL INFECTION, no. 42, 1999, pages 151 - 154 † |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102014003484A1 (en) | 2014-03-14 | 2015-09-17 | Bode Chemie Gmbh | Cleaner for inanimate surfaces with special effectiveness against mucus, secretions, blood and biofilms |
Also Published As
Publication number | Publication date |
---|---|
DE50105092D1 (en) | 2005-02-24 |
EP1126013A1 (en) | 2001-08-22 |
DE10007323A1 (en) | 2001-08-23 |
ATE287442T1 (en) | 2005-02-15 |
EP1126013B1 (en) | 2005-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69512841T2 (en) | Skin disinfection formulation | |
DE69524631T2 (en) | SYNERGISTIC DISINFECTION AND DETERGENT COMBINATION FOR THE DECONTAMINATION OF A BIOFILM COATED SURFACE | |
DE602004008454T2 (en) | CLEANING AND DECONTAMINATION FORMULAS FOR SURFACES CONTAMINATED WITH PRENINE INFECTED MATERIAL | |
DE69832601T2 (en) | ALKYLPOLYGLYCOSIDE-BASED, PSEUDOMONAS MICRO-ORGANISMS EFFECTIVE DISINFECTANT | |
DE69523161T2 (en) | SALT SOLUTION FOR THE TREATMENT OF CONTACT LENSES | |
DE69714018T2 (en) | QUICK-ACTING CHEMICAL STERILIZER | |
DE69608507T2 (en) | Procedures for cleaning and disinfecting contact lenses | |
EP1470211B1 (en) | Cleaning and disinfection of surgical and medical instruments and appliances | |
DE19603977A1 (en) | Process for cleaning and disinfecting sensitive medical devices | |
DE60219403T2 (en) | Process for the preparation of a disinfecting composition, disinfection method for medical devices | |
DE10030946A1 (en) | Cleaning and disinfection systems for medical instruments | |
EP1126012B1 (en) | Cleaning and sanitizing systems for medical devices | |
EP1126013B2 (en) | Cleaning composition for medical devices | |
DE69116497T2 (en) | Combined two-stage process for cleaning and disinfecting surgical instruments | |
EP0994178B1 (en) | Cleaning compositions and their use | |
DE60015867T2 (en) | Aqueous solution of peracetic acid and hydrogen peroxide for the disinfection of endoscopes | |
DE102011077432A1 (en) | Use of bispyridiniumalkanes to kill spores | |
DE19814829C2 (en) | Water-based cleaners and disinfectants, their use and methods for automated simultaneous cleaning and disinfection of medical instruments, in particular endoscopes | |
EP1126014B1 (en) | Cleaning and sanitizing systems for medical devices | |
DE60014520T2 (en) | Disinfection of endoscopes with an aqueous solution of peracetic acid and hydrogen peroxide | |
DE2436905B2 (en) | Sterile, isotonic aqueous preparation for sterilizing soft contact lenses | |
EP1454638B1 (en) | Concentrated disinfecting composition based on quaternary ammonium compounds and their use for chemical-thermal care for instruments | |
EP2617867B1 (en) | Method and composition for preparing medical instruments | |
DE102004047247B3 (en) | Sterilization process for the production of implantable or transplantable biological material | |
EP1138203A2 (en) | Disinfection systems with microbicidal activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
17P | Request for examination filed |
Effective date: 20010914 |
|
AKX | Designation fees paid |
Free format text: AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
17Q | First examination report despatched |
Effective date: 20030902 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED. Effective date: 20050119 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050119 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050119 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20050119 Ref country code: IE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050119 Ref country code: GB Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050119 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: GERMAN |
|
REF | Corresponds to: |
Ref document number: 50105092 Country of ref document: DE Date of ref document: 20050224 Kind code of ref document: P |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050419 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050419 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050419 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050430 |
|
NLV1 | Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act | ||
GBV | Gb: ep patent (uk) treated as always having been void in accordance with gb section 77(7)/1977 [no translation filed] |
Effective date: 20050119 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FD4D |
|
PLBI | Opposition filed |
Free format text: ORIGINAL CODE: 0009260 |
|
PLAX | Notice of opposition and request to file observation + time limit sent |
Free format text: ORIGINAL CODE: EPIDOSNOBS2 |
|
26 | Opposition filed |
Opponent name: ECOLAB INC. Effective date: 20050929 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: BOVARD AG PATENTANWAELTE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20060131 Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20060131 |
|
EN | Fr: translation not filed | ||
PLAS | Information related to reply of patent proprietor to notice(s) of opposition deleted |
Free format text: ORIGINAL CODE: EPIDOSDOBS3 |
|
PLBB | Reply of patent proprietor to notice(s) of opposition received |
Free format text: ORIGINAL CODE: EPIDOSNOBS3 |
|
RAP2 | Party data changed (patent owner data changed or rights of a patent transferred) |
Owner name: BODE CHEMIE GMBH & CO. KG |
|
BECN | Be: change of holder's name |
Owner name: BODE CHEMIE G.M.B.H. & CO. K.G. Effective date: 20050119 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PFA Owner name: BODE CHEMIE GMBH & CO. KG Free format text: BODE CHEMIE GMBH & CO.#MELANCHTHONSTRASSE 27#22525 HAMBURG (DE) -TRANSFER TO- BODE CHEMIE GMBH & CO. KG#MELANCHTHONSTRASSE 27#22525 HAMBURG (DE) |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050119 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050119 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PFA Owner name: BODE CHEMIE GMBH Free format text: BODE CHEMIE GMBH & CO. KG#MELANCHTHONSTRASSE 27#22525 HAMBURG (DE) -TRANSFER TO- BODE CHEMIE GMBH#MELANCHTHONSTRASSE 27#22525 HAMBURG (DE) |
|
APBM | Appeal reference recorded |
Free format text: ORIGINAL CODE: EPIDOSNREFNO |
|
APBP | Date of receipt of notice of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA2O |
|
APAH | Appeal reference modified |
Free format text: ORIGINAL CODE: EPIDOSCREFNO |
|
APBM | Appeal reference recorded |
Free format text: ORIGINAL CODE: EPIDOSNREFNO |
|
APBP | Date of receipt of notice of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA2O |
|
APBQ | Date of receipt of statement of grounds of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA3O |
|
APBQ | Date of receipt of statement of grounds of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA3O |
|
PLAB | Opposition data, opponent's data or that of the opponent's representative modified |
Free format text: ORIGINAL CODE: 0009299OPPO |
|
PLAB | Opposition data, opponent's data or that of the opponent's representative modified |
Free format text: ORIGINAL CODE: 0009299OPPO |
|
R26 | Opposition filed (corrected) |
Opponent name: ECOLAB INC. Effective date: 20050929 |
|
RAP2 | Party data changed (patent owner data changed or rights of a patent transferred) |
Owner name: BODE CHEMIE GMBH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PFA Owner name: BODE CHEMIE GMBH Free format text: BODE CHEMIE GMBH#MELANCHTHONSTRASSE 27#22525 HAMBURG (DE) -TRANSFER TO- BODE CHEMIE GMBH#MELANCHTHONSTRASSE 27#22525 HAMBURG (DE) |
|
APBU | Appeal procedure closed |
Free format text: ORIGINAL CODE: EPIDOSNNOA9O |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050119 |
|
PLAY | Examination report in opposition despatched + time limit |
Free format text: ORIGINAL CODE: EPIDOSNORE2 |
|
PLBC | Reply to examination report in opposition received |
Free format text: ORIGINAL CODE: EPIDOSNORE3 |
|
PUAH | Patent maintained in amended form |
Free format text: ORIGINAL CODE: 0009272 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: PATENT MAINTAINED AS AMENDED |
|
27A | Patent maintained in amended form |
Effective date: 20130327 |
|
AK | Designated contracting states |
Kind code of ref document: B2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: AELC |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R102 Ref document number: 50105092 Country of ref document: DE Effective date: 20130327 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20180125 Year of fee payment: 18 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20180122 Year of fee payment: 18 Ref country code: BE Payment date: 20180124 Year of fee payment: 18 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20190124 Year of fee payment: 19 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 287442 Country of ref document: AT Kind code of ref document: T Effective date: 20190103 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20190131 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190131 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190131 Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190103 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190131 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 50105092 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200801 |